NO20071052L - Fremgangsmater for behandling av proliferative hudsykdommer ved bruk av karbazolderivater - Google Patents
Fremgangsmater for behandling av proliferative hudsykdommer ved bruk av karbazolderivaterInfo
- Publication number
- NO20071052L NO20071052L NO20071052A NO20071052A NO20071052L NO 20071052 L NO20071052 L NO 20071052L NO 20071052 A NO20071052 A NO 20071052A NO 20071052 A NO20071052 A NO 20071052A NO 20071052 L NO20071052 L NO 20071052L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- methods
- proliferative skin
- skin diseases
- carbazole derivatives
- Prior art date
Links
- 230000002062 proliferating effect Effects 0.000 title abstract 2
- 208000017520 skin disease Diseases 0.000 title abstract 2
- 125000000609 carbazolyl group Chemical class C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60920304P | 2004-09-10 | 2004-09-10 | |
| US11/222,409 US20060058250A1 (en) | 2004-09-10 | 2005-09-08 | Methods of treating proliferative skin diseases using carbazole derivatives |
| PCT/US2005/032489 WO2006031772A1 (en) | 2004-09-10 | 2005-09-09 | Methods of treating proliferative skin diseases using carbazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20071052L true NO20071052L (no) | 2007-04-03 |
Family
ID=36034857
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20071052A NO20071052L (no) | 2004-09-10 | 2007-02-23 | Fremgangsmater for behandling av proliferative hudsykdommer ved bruk av karbazolderivater |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060058250A1 (https=) |
| EP (1) | EP1786418A1 (https=) |
| JP (1) | JP2008512497A (https=) |
| KR (1) | KR20070113186A (https=) |
| AR (1) | AR050930A1 (https=) |
| AU (1) | AU2005285007A1 (https=) |
| BR (1) | BRPI0515115A (https=) |
| CA (1) | CA2577024A1 (https=) |
| IL (1) | IL181003A0 (https=) |
| MX (1) | MX2007002532A (https=) |
| MY (1) | MY156431A (https=) |
| NO (1) | NO20071052L (https=) |
| TW (1) | TW200621266A (https=) |
| WO (1) | WO2006031772A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR114110A1 (es) | 2018-02-28 | 2020-07-22 | Lilly Co Eli | Anticuerpo anti-trka |
| WO2021138391A1 (en) | 2019-12-30 | 2021-07-08 | Tyra Biosciences, Inc. | Indazole compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
| DK1044203T3 (da) * | 1997-12-31 | 2003-07-14 | Cephalon Inc | 3'-epimere K-252a-derivater |
| US6127401A (en) * | 1998-06-05 | 2000-10-03 | Cephalon, Inc. | Bridged indenopyrrolocarbazoles |
| US6013646A (en) * | 1998-07-02 | 2000-01-11 | Bayer Corporation | Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| US6399780B1 (en) * | 1999-08-20 | 2002-06-04 | Cephalon, Inc. | Isomeric fused pyrrolocarbazoles and isoindolones |
| EP1309721A2 (en) * | 2000-08-11 | 2003-05-14 | Cephalon, Inc. | Modulating multiple lineage kinase proteins |
| US6667173B2 (en) * | 2000-12-01 | 2003-12-23 | The Schepens Eye Research Institute | Nucleic acids encoding platelet derived growth factor-alpha receptors |
| US7241779B2 (en) * | 2003-12-23 | 2007-07-10 | Cephalon, Inc. | Fused pyrrolocarbazoles |
-
2005
- 2005-09-08 US US11/222,409 patent/US20060058250A1/en not_active Abandoned
- 2005-09-09 JP JP2007531441A patent/JP2008512497A/ja not_active Withdrawn
- 2005-09-09 AR ARP050103785A patent/AR050930A1/es unknown
- 2005-09-09 CA CA002577024A patent/CA2577024A1/en not_active Abandoned
- 2005-09-09 KR KR1020077008005A patent/KR20070113186A/ko not_active Withdrawn
- 2005-09-09 EP EP05796536A patent/EP1786418A1/en not_active Ceased
- 2005-09-09 AU AU2005285007A patent/AU2005285007A1/en not_active Abandoned
- 2005-09-09 MY MYPI20054257A patent/MY156431A/en unknown
- 2005-09-09 BR BRPI0515115-5A patent/BRPI0515115A/pt not_active IP Right Cessation
- 2005-09-09 WO PCT/US2005/032489 patent/WO2006031772A1/en not_active Ceased
- 2005-09-09 TW TW094131097A patent/TW200621266A/zh unknown
- 2005-09-09 MX MX2007002532A patent/MX2007002532A/es not_active Application Discontinuation
-
2007
- 2007-01-28 IL IL181003A patent/IL181003A0/en unknown
- 2007-02-23 NO NO20071052A patent/NO20071052L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008512497A (ja) | 2008-04-24 |
| BRPI0515115A (pt) | 2008-07-01 |
| MX2007002532A (es) | 2007-05-09 |
| EP1786418A1 (en) | 2007-05-23 |
| AR050930A1 (es) | 2006-12-06 |
| IL181003A0 (en) | 2007-07-04 |
| TW200621266A (en) | 2006-07-01 |
| AU2005285007A1 (en) | 2006-03-23 |
| KR20070113186A (ko) | 2007-11-28 |
| WO2006031772A1 (en) | 2006-03-23 |
| US20060058250A1 (en) | 2006-03-16 |
| MY156431A (en) | 2016-02-26 |
| CA2577024A1 (en) | 2006-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200870373A1 (ru) | Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ | |
| MX2012002761A (es) | Bipiridinas utiles para el tratamiento de enfermedades proliferativas. | |
| MX2009008338A (es) | Compuestos de piridopirimidinona de utilidad en el tratamiento de enfermedades o condiciones patologicas mediadas por los canales de sodio. | |
| AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
| EA201391263A1 (ru) | Комбинированные терапии гематологических опухолей | |
| EA200970611A1 (ru) | Замещенные пиразолохиназолиновые производные, способ их получения и их применение в качестве ингибиторов киназы | |
| ATE537175T1 (de) | Neue piperazino-dihydrothienopyrimidin-derivate | |
| WO2001081312A3 (en) | Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore | |
| EA201890903A9 (ru) | Соединения пиридиловых ингибиторов передачи сигналов белком hedgehog, способ их получения, композиция и способы лечения рака и ингибирований ангиогенеза и сигнального пути hedgehog в клетках на их основе | |
| EA200700851A1 (ru) | Получение и применение бифенил-4-илкарбониламинокислотных производных для лечения ожирения | |
| EA201691142A1 (ru) | Ингибиторы мек и способы их применения | |
| EA201101507A1 (ru) | Способы лечения солидных опухолей | |
| MX2012002758A (es) | Pirazinil-piridinas utiles para el tratamiento de enfermedades proliferativas. | |
| ATE517882T1 (de) | Chinolinderivate | |
| DE602004024900D1 (de) | Substituierte 2,3-dihydro-1h-isoindol-1-one derivate und anwendungsverfahren | |
| EA200702387A1 (ru) | Имидазохинолины в качестве ингибиторов липидкиназы | |
| EA201070442A1 (ru) | НОВЫЕ ИНГИБИТОРЫ sEH И ИХ ПРИМЕНЕНИЕ | |
| RU2010144637A (ru) | Замещенные гамма-лактамы в качестве терапевтических агентов | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| NO20073170L (no) | Kaspaseinhibitorer og anvendelse derav | |
| EA200801245A1 (ru) | [4-(6-галоген-7-замещенные-2,4-диоксо-1,4-дигидро-2н-хиназолин-3-ил)фенил]-5-хлортиофен-2-илсульфонилмочевины и формы и способы, связанные с ними | |
| NO330888B1 (no) | Benzensylfonamidderivater, fremgangsmate for fremstilling av slike, terapeutisk preparatinneholdende slike samt anvendelse av slike for fremstilling av preparat for behandling av sykdom | |
| WO2008109856A3 (en) | Methods of using diazepinone compounds in treating sodium channel-mediated diseases or conditions | |
| WO2006081431A3 (en) | Compounds for treating inflammatory and demyelinating diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |